These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 39122224)
1. LncRNA KCNQ1OT1 promotes NLRP3 inflammasome activation in Parkinson's disease by regulating pri-miR-186/mature miR-186/NLRP3 axis. Li MM; Shi MJ; Feng CC; Yu ZY; Bai XF; Lu-Lu Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167454. PubMed ID: 39122224 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease. Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336 [TBL] [Abstract][Full Text] [Related]
3. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells. Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301 [TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway. Cao B; Wang T; Qu Q; Kang T; Yang Q Neuroscience; 2018 Sep; 388():118-127. PubMed ID: 30031125 [TBL] [Abstract][Full Text] [Related]
5. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072 [TBL] [Abstract][Full Text] [Related]
6. miR-29c-3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease. Wang R; Li Q; He Y; Yang Y; Ma Q; Li C Genes Cells; 2020 Jun; 25(6):364-374. PubMed ID: 32160394 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model. Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472 [TBL] [Abstract][Full Text] [Related]
8. LncRNA-Meg3 promotes Nlrp3-mediated microglial inflammation by targeting miR-7a-5p. Meng J; Ding T; Chen Y; Long T; Xu Q; Lian W; Liu W Int Immunopharmacol; 2021 Jan; 90():107141. PubMed ID: 33189612 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis. Cao H; Han X; Jia Y; Zhang B Aging (Albany NY); 2021 Apr; 13(8):11455-11469. PubMed ID: 33839699 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson's disease by regulating NLRP3 pathway through sponging miR-223-3p. Xu W; Zhang L; Geng Y; Liu Y; Zhang N Int Immunopharmacol; 2020 Aug; 85():106614. PubMed ID: 32470877 [TBL] [Abstract][Full Text] [Related]
11. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis. Liu L; Zhou T; Li T; Liang Z; Luo X Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840 [TBL] [Abstract][Full Text] [Related]
12. The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients' studies in Parkinson's disease. Li T; Tan X; Tian L; Jia C; Cheng C; Chen X; Wei M; Wang Y; Hu Y; Jia Q; Ni Y; Al-Nusaif M; Li S; Le W J Neuroinflammation; 2023 Nov; 20(1):274. PubMed ID: 37990334 [TBL] [Abstract][Full Text] [Related]
13. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861 [TBL] [Abstract][Full Text] [Related]
14. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome. Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454 [TBL] [Abstract][Full Text] [Related]
15. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia. He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118 [TBL] [Abstract][Full Text] [Related]
16. The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson's disease. Li Y; Yu C; Jiang X; Fu J; Sun N; Zhang D Pathol Res Pract; 2024 Jun; 258():155349. PubMed ID: 38772115 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating Zhang C; Gong Y; Li N; Liu X; Zhang Y; Ye F; Guo Q; Zheng J Am J Physiol Cell Physiol; 2021 Mar; 320(3):C355-C364. PubMed ID: 33296289 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3. Li D; Yang H; Ma J; Luo S; Chen S; Gu Q Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035 [TBL] [Abstract][Full Text] [Related]
20. RND3 modulates microglial polarization and alleviates neuroinflammation in Parkinson's disease by suppressing NLRP3 inflammasome activation. Hu W; Wang M; Sun G; Zhang L; Lu H Exp Cell Res; 2024 Jun; 439(1):114088. PubMed ID: 38744409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]